These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 9727072)

  • 21. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
    Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
    Toth MJ; Sites CK; Matthews DE
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and body composition in Turner syndrome: Effect of sequential change in the route of estrogen administration.
    Alves ST; Gallichio CT; Guimarães MM
    Gynecol Endocrinol; 2006 Oct; 22(10):590-4. PubMed ID: 17135039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
    Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
    J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY; Leung KC; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women.
    Friedlander AL; Butterfield GE; Moynihan S; Grillo J; Pollack M; Holloway L; Friedman L; Yesavage J; Matthias D; Lee S; Marcus R; Hoffman AR
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1496-503. PubMed ID: 11297574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
    Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
    Dobs AS; Nguyen T; Pace C; Roberts CP
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB; Silfverstolpe G; Tengborn L
    Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ
    Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.